Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine

Author:                  

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.43, Iss.2, 2013-01, pp. : 670-676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content